# Neurontin

NDC: 0071-0806
Generic name: gabapentin
Labeler / Manufacturer: Parke-Davis Div of Pfizer Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 19931230
Marketing ended: 20260731
FDA application: NDA020235

## Active ingredients

- GABAPENTIN: 400 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0071-0806"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0071-0806
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388